查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1947109

2026年全球自行注射市場報告

Self-Injections Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，自行注射市場發展迅猛，預計將從2025年的102.2億美元成長到2026年的110.4億美元，複合年成長率達8.1%。過去幾年的成長可歸因於多種因素，例如慢性病盛行率的上升、注射用生物製藥的日益普及、居家治療需求的增加、專科製藥行業的擴張以及注射裝置人體工學的改進。

預計未來幾年，自行注射市場將維持強勁成長，2030年市場規模將達到150.5億美元，複合年成長率（CAGR）為8.1%。預測期內的成長可歸因於對自我護理療法的需求不斷成長、數位化健康注射器的普及、生物製藥研發管線的不斷擴大、對提高患者依從性的藥物輸送方式的日益重視以及互聯醫療設備的使用日益增多。預測期內的主要趨勢包括：自動注射器的普及率不斷提高、對穿戴式注射系統的需求不斷成長、生物製劑自我給藥療法的使用日益廣泛、以患者為中心的藥物輸送設計方案日益增多，以及對安全性和劑量準確性的日益重視。

預計未來幾年，糖尿病盛行率的不斷上升將推動自行注射市場的發展。糖尿病是一種胰臟（負責產生胰島素的器官）無法產生足夠胰島素的疾病，會導致血糖值調節受損，並引發心血管疾病、視力障礙和腎臟損傷等嚴重併發症。自行注射裝置使糖尿病患者能夠獨立注射胰島素和其他藥物，幫助他們維持理想的血糖值，並防止血糖過度積聚，而無需依賴醫療專業人員。例如，根據國際同儕審查醫學期刊《糖尿病照護》（Diabetes Care）的數據，截至2024年，約有6.348億人（佔全球成年人口的12.0%）患有葡萄糖耐受不良。預計到2050年，這一數字將增加至8.465億（佔全球成年人口的12.9%）。因此，糖尿病患者數量的不斷成長顯著推動了自行注射市場的發展。

領先的自行注射市場主要企業正日益重視藥物傳輸技術的創新，包括旨在簡化患者自行注射大劑量生物製藥製劑的免手持式和隱藏式針頭皮下注射系統。免手持式和隱藏式針頭皮下注射系統採用穿戴式式注射器，可在自動注射藥物的同時隱藏針頭，從而提高舒適性、安全性和易用性。例如，2023年11月，總部位於美國的藥物傳輸技術公司Enable Injections Inc.獲得了美國食品藥物管理局（FDA）對其enFuse的首個核准。 enFuse是一款大劑量穿戴式注射器，用於EMPAVELI（培西妥昔單抗）。這款小巧的機械式穿戴式系統可皮下注射高達25毫升的藥物，支持患者自行注射和在醫療機構使用。其特點包括免手持操作，並將對患者日常生活的影響降至最低。 enFuse 平台增強了大容量治療的便利性，促進了居家照護，並改善了患者的整體體驗。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球自行注射市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 工業4.0和智慧製造
    • 數位化、雲端運算、巨量資料、網路安全
    • 永續性、氣候技術和循環經濟
    • 人工智慧（AI）和自主人工智慧
  • 主要趨勢
    • 自動注射器的使用日益普及
    • 對穿戴式注射系統的需求不斷成長
    • 擴大自我給藥生物製藥療法的應用
    • 擴展以病人為中心的藥物傳輸設計
    • 更加重視安全性和劑量準確性

第5章 終端用戶產業市場分析

  • 製藥公司
  • 生技公司
  • 醫院和診所
  • 居家醫療保健服務提供者
  • 專科藥房

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球自行注射市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球自行注射市場規模、對比及成長率分析
  • 全球自行注射市場表現：規模與成長，2020-2025年
  • 全球自行注射市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按類型
  • 設備、配方
  • 按劑量
  • 單劑量，多劑量
  • 透過使用
  • 自體免疫疾病、內分泌失調、罕見疾病、疼痛管理及其他適應症
  • 透過分銷管道
  • 藥局，網路藥局
  • 按類型細分：設備
  • 預填充式注射器、自動注射器、微針裝置、穿戴式注射器
  • 按類型細分：製劑
  • 生物製藥、小分子化合物、複方製劑

第10章 區域與國家分析

  • 全球自行注射市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球自行注射市場：依國家、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 自行注射市場：競爭格局及市場佔有率（2024年）
  • 自行注射市場：公司估值矩陣
  • 自行注射市場：公司簡介
    • AbbVie Inc.
    • Antares Pharma Inc.
    • Baxter International Inc.
    • Bayer AG
    • Becton Dickinson and Company

第37章：其他領先和創新企業

  • Bristol-Myers Squibb Company, Credence MedSystems Inc., Dali Medical Devices Ltd., Eli Lilly and Company, Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Merck & Co. Inc., Owen Mumford Limited, Pfizer Inc., PharmaJet Inc., Recipharm AB, Schott AG, SHL Group Limited, Terumo Corporation

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年自行注射市場：提供新機會的國家
  • 2030年自行注射市場：充滿新機會的細分市場
  • 2030年自行注射市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MSINJ01_G26Q1

Self-injection refers to the act of administering medications or drugs through a device by an individual to themselves without the assistance of a medical professional. This practice allows patients to independently manage their medication regimen.

The primary types of self-injections encompass devices and formulations. These devices enable patients to self-administer medications that require injection without relying on medical professionals. Self-injection devices are utilized for various routes of administration such as skin, circulatory or musculoskeletal systems, organs, and the central nervous system. Dosage types include single-dose and multi-dose, catering to applications in autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, among others. These devices are distributed through various channels including hospitals, pharmacies, clinics, chemists, and online pharmacies.

Tariffs are influencing the self-injections market by increasing costs of imported medical-grade plastics, precision springs, electronic components, and sterile manufacturing equipment used in auto-injectors and wearable devices. Pharmaceutical and device manufacturers in North America and Europe are most affected due to cross-border component sourcing, while Asia-Pacific faces cost pressure on device exports. These tariffs are raising device production costs and pricing pressures. However, they are also encouraging localized device assembly, regional supplier partnerships, and investment in domestic medical device manufacturing capabilities.

The self-injections market research report is one of a series of new reports from The Business Research Company that provides self-injections market statistics, including self-injections industry global market size, regional shares, competitors with a self-injections market share, detailed self-injections market segments, market trends and opportunities, and any further data you may need to thrive in the self-injections industry. This self-injections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The self-injections market size has grown strongly in recent years. It will grow from $10.22 billion in 2025 to $11.04 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to growth in chronic disease prevalence, increasing availability of injectable biologics, rising preference for home-based treatment, expansion of specialty pharmaceuticals, improvements in injection device ergonomics.

The self-injections market size is expected to see strong growth in the next few years. It will grow to $15.05 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing demand for self-care therapies, rising adoption of digital health-enabled injectors, expansion of biologics pipelines, growing focus on adherence-enhancing drug delivery, increasing use of connected medical devices. Major trends in the forecast period include increasing adoption of auto-injector devices, rising demand for wearable injection systems, growing use of biologic self-administered therapies, expansion of patient-centric drug delivery designs, enhanced focus on safety and dose accuracy.

The increasing prevalence of diabetes is expected to drive the expansion of the self-injections market in the coming years. Diabetes is a medical condition in which the pancreas, the organ responsible for insulin production, generates insufficient insulin, resulting in impaired blood sugar regulation and leading to serious complications such as cardiovascular disease, vision impairment, and kidney disorders. Self-injection devices allow individuals with diabetes to administer insulin and other therapies independently, helping them maintain optimal blood glucose levels and prevent excess sugar accumulation without reliance on healthcare professionals. For example, in November 2025, according to Diabetes Care, a United States-based international peer-reviewed medical journal, an estimated 634.8 million adults, representing 12.0 percent of the global adult population, were living with impaired glucose tolerance in 2024, a figure projected to rise to 846.5 million adults or 12.9 percent of the global adult population by 2050. As a result, the rising number of people with diabetes is contributing significantly to the growth of the self-injections market.

Leading companies operating in the self-injections market are increasingly prioritizing innovations in drug-delivery technologies, including hands-free and hidden-needle subcutaneous systems designed to simplify patient self-administration of large-volume biologic therapies. Hands-free, hidden-needle subcutaneous delivery involves wearable injectors that automatically deliver medication while concealing the needle, thereby improving comfort, safety, and ease of use. For instance, in November 2023, Enable Injections Inc., a United States-based drug-delivery technology company, received its first approval from the United States Food and Drug Administration for the enFuse large-volume wearable injector for use with EMPAVELI (pegcetacoplan). This compact, mechanical, body-worn system is capable of delivering up to 25 milliliters subcutaneously and supports both self-administration and in-clinic use, offering features such as hands-free operation and minimal disruption to patients' daily activities. The enFuse platform enhances convenience, promotes home-based care, and improves the overall patient experience for large-volume therapy delivery.

In May 2024, Enable Injections, Inc., a United States-based developer and manufacturer of the enFuse wearable drug-delivery platform, entered into a partnership with Roche Holding AG to apply the enFuse system to selected Roche molecules for subcutaneous administration. Through this collaboration, Enable Injections seeks to broaden access to large-volume self-administration therapies by enabling a transition from intravenous treatments to at-home subcutaneous delivery for a wider patient population. Roche Holding AG is a Switzerland-based pharmaceutical company with a strong focus on biologics and drug-device combination development.

Major companies operating in the self-injections market are AbbVie Inc., Antares Pharma Inc., Baxter International Inc., Bayer AG, Becton Dickinson and Company, Bristol-Myers Squibb Company, Credence MedSystems Inc., Dali Medical Devices Ltd., Eli Lilly and Company, Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Merck & Co. Inc., Owen Mumford Limited, Pfizer Inc., PharmaJet Inc., Recipharm AB, Schott AG, SHL Group Limited, Terumo Corporation, West Pharmaceutical Services Inc., Wilhelm Haselmeier GmbH & Co. KG, Ypsomed Holding AG, APTAR PHARMA INDIA PVT LTD, Bespak Europe Ltd., Bioject Medical Technologies Inc., Catalent Inc., Crossject SA, Injex Pharma AG, Medeca Pharma AB, Medimop Medical Projects Ltd., Mylan N.V., Nemera Development S.A., Noble Medical Inc.

North America was the largest region in the self-injections market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-injections market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the self-injections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The self injections market consists of sales of auto-injectors, needle-free injectors, pen injectors and wearable injectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Self-Injections Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses self-injections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for self-injections ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The self-injections market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Devices; Formulations
  • 2) By Dosage: Single Dose; Multi Dose
  • 3) By Application: Autoimmune Diseases; Hormonal Disorders; Orphan Diseases; Pain Management; Other Applications
  • 4) By Distribution Channel: Chemist; Online Pharmacies
  • Subsegments:
  • 1) By Devices: Pre-Filled Syringes; Auto-Injectors; Microneedle Devices; Wearable Injectors
  • 2) By Formulations: Biologics; Small Molecules; Combination Products
  • Companies Mentioned: AbbVie Inc.; Antares Pharma Inc.; Baxter International Inc.; Bayer AG; Becton Dickinson and Company; Bristol-Myers Squibb Company; Credence MedSystems Inc.; Dali Medical Devices Ltd.; Eli Lilly and Company; Enable Injections Inc.; Gerresheimer AG; Insulet Corporation; Merck & Co. Inc.; Owen Mumford Limited; Pfizer Inc.; PharmaJet Inc.; Recipharm AB; Schott AG; SHL Group Limited; Terumo Corporation; West Pharmaceutical Services Inc.; Wilhelm Haselmeier GmbH & Co. KG; Ypsomed Holding AG; APTAR PHARMA INDIA PVT LTD; Bespak Europe Ltd.; Bioject Medical Technologies Inc.; Catalent Inc.; Crossject SA; Injex Pharma AG; Medeca Pharma AB; Medimop Medical Projects Ltd.; Mylan N.V.; Nemera Development S.A.; Noble Medical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Self-Injections Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Self-Injections Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Self-Injections Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Self-Injections Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Sustainability, Climate Tech & Circular Economy
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Auto-Injector Devices
    • 4.2.2 Rising Demand For Wearable Injection Systems
    • 4.2.3 Growing Use Of Biologic Self-Administered Therapies
    • 4.2.4 Expansion Of Patient-Centric Drug Delivery Designs
    • 4.2.5 Enhanced Focus On Safety And Dose Accuracy

5. Self-Injections Market Analysis Of End Use Industries

  • 5.1 Pharmaceutical Companies
  • 5.2 Biotechnology Companies
  • 5.3 Hospitals And Clinics
  • 5.4 Home Healthcare Providers
  • 5.5 Specialty Pharmacies

6. Self-Injections Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Self-Injections Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Self-Injections PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Self-Injections Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Self-Injections Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Self-Injections Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Self-Injections Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Self-Injections Market Segmentation

  • 9.1. Global Self-Injections Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Devices, Formulations
  • 9.2. Global Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single Dose, Multi Dose
  • 9.3. Global Self-Injections Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Pain Management, Other Applications
  • 9.4. Global Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Chemist, Online Pharmacies
  • 9.5. Global Self-Injections Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pre-Filled Syringes, Auto-Injectors, Microneedle Devices, Wearable Injectors
  • 9.6. Global Self-Injections Market, Sub-Segmentation Of Formulations, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Biologics, Small Molecules, Combination Products

10. Self-Injections Market Regional And Country Analysis

  • 10.1. Global Self-Injections Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Self-Injections Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Self-Injections Market

  • 11.1. Asia-Pacific Self-Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Self-Injections Market

  • 12.1. China Self-Injections Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Self-Injections Market

  • 13.1. India Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Self-Injections Market

  • 14.1. Japan Self-Injections Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Self-Injections Market

  • 15.1. Australia Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Self-Injections Market

  • 16.1. Indonesia Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Self-Injections Market

  • 17.1. South Korea Self-Injections Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Self-Injections Market

  • 18.1. Taiwan Self-Injections Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Self-Injections Market

  • 19.1. South East Asia Self-Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Self-Injections Market

  • 20.1. Western Europe Self-Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Self-Injections Market

  • 21.1. UK Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Self-Injections Market

  • 22.1. Germany Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Self-Injections Market

  • 23.1. France Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Self-Injections Market

  • 24.1. Italy Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Self-Injections Market

  • 25.1. Spain Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Self-Injections Market

  • 26.1. Eastern Europe Self-Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Self-Injections Market

  • 27.1. Russia Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Self-Injections Market

  • 28.1. North America Self-Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Self-Injections Market

  • 29.1. USA Self-Injections Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Self-Injections Market

  • 30.1. Canada Self-Injections Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Self-Injections Market

  • 31.1. South America Self-Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Self-Injections Market

  • 32.1. Brazil Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Self-Injections Market

  • 33.1. Middle East Self-Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Self-Injections Market

  • 34.1. Africa Self-Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Self-Injections Market, Segmentation By Type, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Self-Injections Market Regulatory and Investment Landscape

36. Self-Injections Market Competitive Landscape And Company Profiles

  • 36.1. Self-Injections Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Self-Injections Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Self-Injections Market Company Profiles
    • 36.3.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Antares Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

37. Self-Injections Market Other Major And Innovative Companies

  • Bristol-Myers Squibb Company, Credence MedSystems Inc., Dali Medical Devices Ltd., Eli Lilly and Company, Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Merck & Co. Inc., Owen Mumford Limited, Pfizer Inc., PharmaJet Inc., Recipharm AB, Schott AG, SHL Group Limited, Terumo Corporation

38. Global Self-Injections Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Self-Injections Market

40. Self-Injections Market High Potential Countries, Segments and Strategies

  • 40.1 Self-Injections Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Self-Injections Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Self-Injections Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer